Morphine oral liquid was previously manufactured by Pfizer, in Perth. However, in April 2023, Pfizer divested the Perth manufacturing plant to Bridgewest and stopped manufacturing morphine oral liquid (RA-Morph) to Bridgewest's nominated New Zealand supplier, Juno Pharmaceuticals.1
Bridgewest has indicated they can resume manufacturing and supply of morphine oral liquid to New Zealand from April 2024. The five-month gap in supply of morphine oral liquid RA-Morph 1mg/ml will be covered by Wockhardt morphine oral liquid 10mg/5ml.
Sufficient supplies of morphine oral liquid RA-Morph 2mg/ml and 5mg/ml strengths remain. However, supplies of RA-Morph 10mg/ml will run out by the end of November 2023.1